Study reviews BNMs’ role in understanding brain disorders

A research team from the International Research Institute for Artificial Intelligence at Harbin Institute of Technology, Shenzhen, has recently published a comprehensive review in the journal Health Data Science on the application of Brain Network Models (BNMs) in the medical field.

Biogen’s higher Spinraza dose shows better efficacy in Phase II/III trial – Pharmaceutical Technology

Spinal muscular atrophy is a rare neuromuscular disorder that results in the loss of motor neurons and progressive muscle wasting. Caption: Frame Stock Footage via

September 6, 2024

Boehringer agrees to comply with CMS’ price negotiations over blockbuster Jardiance

Boehringer Ingelheim said Wednesday that it will take part in the first round of price negotiations with the Centers for Medicare and Medicaid Services for

September 28, 2023

Bausch + Lomb considers sale: FT

Dive Brief: Bausch + Lomb is exploring a potential sale that would separate the eye care company from parent firm Bausch Health, the Financial Times

September 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.